Literature DB >> 34887330

ORF8/ORF8a: a difference between SARS-CoV-2 and SARS-CoV.

Milad Zandi1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34887330      PMCID: PMC8671798          DOI: 10.1183/13993003.02818-2021

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
To the Editor: Recently in an editorial published as an “early view” paper in the European Respiratory Journal, Hartsell et al. [1] reported that ORF8a has a role in SARS-CoV-2 infection. In figure 1, it was stated that ORF7a, ORF8a and ORF9b locate within the mitochondria and can inhibit RIG1-MAVS (retinoic acid-inducible gene I-mitochondrial antiviral signalling protein)-dependent interferon signalling, enhance viral replication and disrupt mitochondrial function [1], although based on scientific evidence, SARS-CoV-2 lacks ORF8a [2-4].
FIGURE 1

SARS-CoV-2 genome.

SARS-CoV-2 genome. The genome of SARS-CoV-2 contains several accessory genes in the 3′-end of the genome that code nine accessory proteins (3a, 3b, 6, 7a, 7b, 8, 9b, 9c and 10), which are involved in SARS-CoV-2 infection (figure 1) [5]. SARS-CoV-2 ORF8 is a 121-amino acid protein which contains an N-terminal signal sequence which is followed by a predicted Ig-like fold. ORF8 protein has a signal sequence for import into the endoplasmic reticulum to interact with proteins of the host cell [6]. ORF8a is absent in SARS-CoV-2 because of a 29-nucleotide deletion that inactivates the formation of the ORF8ab tandem. ORF8 is split into two separated ORFs (ORF8a and ORF8b) in SARS-CoV. An intact ORF8 is encoded by SARS-CoV-2 that shares the least homology among SARS-CoV-2 and SARS-CoV proteins [7]. SARS-CoV-2 encodes two viral proteins with ion channel activity (viroporin): 3a and E [8], but SARS-CoV encodes three: proteins 3a, E and 8a [9]. In SARS-CoV, ORF8 gene encodes two proteins, ORF8a and ORF8b, which characterise proteins of 39 and 84 amino acids, respectively [10]. ORF8a can induce apoptosis by a mitochondrion-dependent pathway [11]. In SARS-CoV-2, ORF8 has several functions during infection. ORF8 can disrupt IFN-I signalling when exogenously overexpressed in cells; it also downregulates levels of major histocompatibility complex (MHC) class Ι through direct binding [6], however this process is not observed for ORF8a and ORF8b. Furthermore, ORF8 degrades MHC-I via the autophagy pathway. In conclusion, one of the differences between SARS-CoV-2 and SARS-CoV is ORF8/ORF8a, for which the SARS-CoV-2 genome encodes an intact ORF8; however, SARS-CoV encodes two proteins, ORF8a and ORF8b. This one-page PDF can be shared freely online. Shareable PDF ERJ-02818-2021.Shareable
  11 in total

1.  Open reading frame 8a of the human severe acute respiratory syndrome coronavirus not only promotes viral replication but also induces apoptosis.

Authors:  Chia-Yen Chen; Yueh-Hsin Ping; Hsin-Chen Lee; Kuan-Hsuan Chen; Yuan-Ming Lee; Yu-Juin Chan; Te-Cheng Lien; Tjin-Shing Jap; Chi-Hung Lin; Lung-Sen Kao; Yi-Ming Arthur Chen
Journal:  J Infect Dis       Date:  2007-06-19       Impact factor: 5.226

2.  The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι.

Authors:  Yiwen Zhang; Yingshi Chen; Yuzhuang Li; Feng Huang; Baohong Luo; Yaochang Yuan; Baijin Xia; Xiancai Ma; Tao Yang; Fei Yu; Jun Liu; Bingfeng Liu; Zheng Song; Jingliang Chen; Shumei Yan; Liyang Wu; Ting Pan; Xu Zhang; Rong Li; Wenjing Huang; Xin He; Fei Xiao; Junsong Zhang; Hui Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

3.  Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis.

Authors:  Carlos Castaño-Rodriguez; Jose M Honrubia; Javier Gutiérrez-Álvarez; Marta L DeDiego; Jose L Nieto-Torres; Jose M Jimenez-Guardeño; Jose A Regla-Nava; Raul Fernandez-Delgado; Carmina Verdia-Báguena; Maria Queralt-Martín; Grazyna Kochan; Stanley Perlman; Vicente M Aguilella; Isabel Sola; Luis Enjuanes
Journal:  mBio       Date:  2018-05-22       Impact factor: 7.867

4.  Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies?

Authors:  Emily M Hartsell; Mark N Gillespie; Raymond J Langley
Journal:  Eur Respir J       Date:  2022-02-24       Impact factor: 16.671

Review 5.  An overview on the seven pathogenic human coronaviruses.

Authors:  Mina Mobini Kesheh; Parastoo Hosseini; Saber Soltani; Milad Zandi
Journal:  Rev Med Virol       Date:  2021-08-02       Impact factor: 6.989

6.  Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs.

Authors:  Ben Sorum; Sonali S Mali; Christopher M Hoel; David M Kern; Savitha Sridharan; Jonathan P Remis; Daniel B Toso; Abhay Kotecha; Diana M Bautista; Stephen G Brohawn
Journal:  Nat Struct Mol Biol       Date:  2021-06-22       Impact factor: 15.369

Review 7.  SARS-CoV-2: An Overview of Virus Genetics, Transmission, and Immunopathogenesis.

Authors:  Mohamed A Farrag; Haitham M Amer; Rauf Bhat; Maaweya E Hamed; Ibrahim M Aziz; Ayman Mubarak; Turki M Dawoud; Sami G Almalki; Fayez Alghofaili; Ahmad K Alnemare; Raid Saleem Al-Baradi; Bandar Alosaimi; Wael Alturaiki
Journal:  Int J Environ Res Public Health       Date:  2021-06-10       Impact factor: 3.390

Review 8.  Coronavirus biology and replication: implications for SARS-CoV-2.

Authors:  Philip V'kovski; Annika Kratzel; Silvio Steiner; Hanspeter Stalder; Volker Thiel
Journal:  Nat Rev Microbiol       Date:  2020-10-28       Impact factor: 60.633

9.  ORF8a as a viroporin in SARS-CoV-2 infection?

Authors:  Milad Zandi
Journal:  Cytokine Growth Factor Rev       Date:  2021-08-02       Impact factor: 7.638

View more
  2 in total

Review 1.  Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19.

Authors:  Yuan-Yuan Yong; Li Zhang; Yu-Jiao Hu; Jian-Ming Wu; Lu Yan; Yi-Ru Pan; Yong Tang; Lu Yu; Betty Yuen-Kwan Law; Chong-Lin Yu; Jie Zhou; Mao Li; Da-Lian Qin; Xiao-Gang Zhou; An-Guo Wu
Journal:  Clin Immunol       Date:  2022-08-06       Impact factor: 10.190

2.  Ribosome Profiling: A Useful Approach to Discover Hidden Corners of SARS-CoV-2.

Authors:  Milad Zandi; Emad Behboudi; Parisa Zeinali; Saber Soltani; Mohammad Reza Shojaei
Journal:  Cell J       Date:  2022-02       Impact factor: 3.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.